effects of vitamin c to mitigation the incidence of in patient undergoing radiotherapy for breast cancer

Study of radioprotective effects of oral dose vitamin c to mitigate lymphocytopenia in patient undergoing radiotherapy for breast cancer

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20161007030196N2

Enrollment

Registered

2018-11-12

Start date

2018-11-01

Completion date

Unknown

Last updated

2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer. Malignant neoplasm of breast of unspecified site

Interventions

Intervention group:.

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: breast cancer The need for radiotherapy after mastectomy

Exclusion criteria

Exclusion criteria: The history of kidney disease and kidney stones The use of multivitamins

Design outcomes

Primary

Measure	Time frame
Counting peripheral blood lymphocytes. Timepoint: Before entering the study, on days 14 and 28 after starting taking vitamin C. Method of measurement: Isolation of lymphocytes by centrifuge and counting by microscope.	—

Secondary

Measure	Time frame
Total antioxidant capacity. Timepoint: Before starting the intervention and day 28 after taking vitamin C. Method of measurement: Using the Eliza 96 Kit.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactdr.seyed mohammad javad mortazavi

Shiraz University of Medical Sciences

mmortazavi@sums.ac.ir+98 71 3208 3366

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026